Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jochen Utikal
Selma Ugurel

Showing results (221-230 of 490) with videos related to

Pageof 49
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2005
Serum proteomic fingerprinting discriminates between clinical stages and predicts disease progression in melanoma patientsShahid Mian, Selma Ugurel, Erika Parkinson, et al.
Frontiers in Immunology|May 29, 2024
Case report: Durable complete response of a mucosal melanoma of the rectum after neoadjuvant immunotherapy with ipilimumab plus nivolumabOskar Krueger, Robin Eisenburger, Alpaslan Tasdogan, et al.
European Journal of Cancer (Oxford, England : 1990)|May 27, 2011
A first prospective population-based analysis investigating the actual practice of melanoma diagnosis, treatment and follow-upElisabeth Livingstone, Christine Windemuth-Kieselbach, Thomas K Eigentler, et al.
Cancer Medicine|December 22, 2017
Progression patterns under BRAF inhibitor treatment and treatment beyond progression in patients with metastatic melanomaJessica C Hassel, Kristina Buder-Bakhaya, Carolin Bender, et al.
Cancer|July 11, 2008
Combined treatment with pegylated interferon-alpha-2a and dacarbazine in patients with advanced metastatic melanoma: a phase 2 studyAxel Hauschild, Reinhard Dummer, Selma Ugurel, et al.
The Journal of Investigative Dermatology|March 11, 2011
ERCC5 p.Asp1104His and ERCC2 p.Lys751Gln polymorphisms are independent prognostic factors for the clinical course of melanomaDavid Schrama, Dominique Scherer, Michael Schneider, et al.
Scientific Reports|May 25, 2017
Epigenetic priming restores the HLA class-I antigen processing machinery expression in Merkel cell carcinomaCathrin Ritter, Kaiji Fan, Annette Paschen, et al.
Molecular Oncology|October 4, 2025
The neural crest-associated gene ERRFI1 is involved in melanoma progression and resistance toward targeted therapyNina Wang, Qian Sun, Daniel Novak, et al.
Cancers|February 25, 2022
ADCK2 Knockdown Affects the Migration of Melanoma Cells via MYL6Marlene Vierthaler, Qian Sun, Yiman Wang, et al.
International Journal of Cancer|June 16, 2018
SOX2-mediated upregulation of CD24 promotes adaptive resistance toward targeted therapy in melanomaLaura Hüser, Sachindra Sachindra, Karol Granados, et al.
Pageof 49

Showing results (221-230 of 490) with videos related to

Sort By:
Pageof 49
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2005
Serum proteomic fingerprinting discriminates between clinical stages and predicts disease progression in melanoma patientsShahid Mian, Selma Ugurel, Erika Parkinson, et al.
Frontiers in Immunology|May 29, 2024
Case report: Durable complete response of a mucosal melanoma of the rectum after neoadjuvant immunotherapy with ipilimumab plus nivolumabOskar Krueger, Robin Eisenburger, Alpaslan Tasdogan, et al.
European Journal of Cancer (Oxford, England : 1990)|May 27, 2011
A first prospective population-based analysis investigating the actual practice of melanoma diagnosis, treatment and follow-upElisabeth Livingstone, Christine Windemuth-Kieselbach, Thomas K Eigentler, et al.
Cancer Medicine|December 22, 2017
Progression patterns under BRAF inhibitor treatment and treatment beyond progression in patients with metastatic melanomaJessica C Hassel, Kristina Buder-Bakhaya, Carolin Bender, et al.
Cancer|July 11, 2008
Combined treatment with pegylated interferon-alpha-2a and dacarbazine in patients with advanced metastatic melanoma: a phase 2 studyAxel Hauschild, Reinhard Dummer, Selma Ugurel, et al.
The Journal of Investigative Dermatology|March 11, 2011
ERCC5 p.Asp1104His and ERCC2 p.Lys751Gln polymorphisms are independent prognostic factors for the clinical course of melanomaDavid Schrama, Dominique Scherer, Michael Schneider, et al.
Scientific Reports|May 25, 2017
Epigenetic priming restores the HLA class-I antigen processing machinery expression in Merkel cell carcinomaCathrin Ritter, Kaiji Fan, Annette Paschen, et al.
Molecular Oncology|October 4, 2025
The neural crest-associated gene ERRFI1 is involved in melanoma progression and resistance toward targeted therapyNina Wang, Qian Sun, Daniel Novak, et al.
Cancers|February 25, 2022
ADCK2 Knockdown Affects the Migration of Melanoma Cells via MYL6Marlene Vierthaler, Qian Sun, Yiman Wang, et al.
International Journal of Cancer|June 16, 2018
SOX2-mediated upregulation of CD24 promotes adaptive resistance toward targeted therapy in melanomaLaura Hüser, Sachindra Sachindra, Karol Granados, et al.
Pageof 49